Case Series: Simultaneous Use of Long-Acting Injectable Antipsychotics and Vivitrol or Long-Acting Buprenorphine in Dual Diagnosis Patients with Bipolar Disorder and Substance Use Disorders

Key Points

• To evaluate the feasibility and utility of using long-acting injectable antipsychotics alongside Vivitrol or Buprenorphine in patients with dual diagnosis.
• Case series design
• Participants included individuals with bipolar disorder and substance use disorders
• Investigated simultaneous use of antipsychotics with Vivitrol or Sublocade
• Assessed medication adherence and overall patient benefit
• All patients showed benefit from the combination treatment
• Suggests potential value for improving medication adherence
• Implications for future studies on optimal medication combinations and patient selection criteria